UNSPSC 51203104: Voclosporin

This classification denotes an immunosuppressant with the molecular formula C63H111N11O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2PN063X6B1, chemically known as (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhepta-4,6-dienyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone but more generally known as voclosporin, which bears US NIH Compound Identifier 6918486.

UNSPSC 51203104 Voclosporin, a Commodity code, nominally identifies a specific immunosuppressant pharmaceutical, but recent state and local solicitations tagged with this code actually cover a broad range of pharmaceutical procurement and medical supply sourcing — from emergency medical consumables and over-the-counter products to direct-to-manufacturer prescription programs and generic multi-source drug distribution. State and local governments are soliciting under this code to stock emergency response supplies, support pharmacy benefit programs, and establish supplier relationships for medical and pharmaceutical goods through competitive bidding and cooperative purchasing arrangements. Issuing bodies include county health departments (Seminole County, Florida), city fire and rescue services (City of Tampa), state health and human services commissions (Texas HHS), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple states including Oregon).

Recent activity spans Florida, Texas, Minnesota, and Oregon. The City of Tampa issued an IFB on March 25, 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with a response deadline of March 13, 2026 and an estimated contract value of $700,000, designated as sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance released an RFP on January 20, 2026 (response deadline March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with contract terms beginning July 1, 2026 and extending two years for new vendors. The Texas Health and Human Services Commission posted a Request for Information on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription programs serving self-insured employee plans and state agencies. Seminole County, Florida solicited Naloxone and safe drug deactivation systems through an IFB posted June 30, 2026 (due July 26, 2023), seeking 1,900 units of Naloxone and 800 deactivation systems annually with quarterly deliveries to the county's Community Health Building.